To support high-volume production with maximum consistency, Ypsomed develops and industrializes fully automated assembly lines for our flagship platforms, including UnoPen and YpsoMate. These lines ensure reliable, repeatable output that meets strict regulatory and performance standards, whatever the scale.

We provide modular assembly systems tailored to project size and stage, whether clinical or commercial. With systems for low (<150,000 p.a.), mid (<1 million p.a.), and high (>1 million p.a.) production volumes, customers benefit from a scalable infrastructure that adapts as their needs grow.

As part of our strategic partner network, we work closely with leading equipment manufacturers to co-develop ready-to-go final assembly systems. These solutions are tailored to the unique requirements of each device, covering parameters such as assembly forces, inline controls, and packaging integration.

A combination product is only complete once the device and drug container are assembled, labeled, and packaged. To reduce time, risk, and transport costs, this assembly often takes place at the filling site. Ypsomed’s experienced industrialization engineers provide hands-on support at customer and CMO assembly sites, ensuring smooth integration, efficient ramp-up, and long-term operational reliability. This close collaboration and expert guidance helps reduce risk and accelerate time to market.